Abstract:This corrects the article ?Computer-aided approach for the identification of lead molecules as the inhibitors of cholinesterase?s and monoamine oxidases: Novel target for the treatment of Alzheimer disease? published in volume 89, number 2, page 117 (https://doi.org/10.2298/JSC230307050E). CONTENT OF THE CORRECTION For author Ammara Fayyaz, additional affiliation is added. Previous affiliation was: 1Department of Pharmaceutical Chemistry, Faculty of Pharmacy, The Islamia University of Bahawalpur, Bahawalpur 63100, Pakistan Corrected affiliation for Ammara Fayyaz: 1Department of Pharmaceutical Chemistry, Faculty of Pharmacy, The Islamia University of Bahawalpur, Bahawalpur 63100, Pakistan, 4School of Pharmaceutical Science and Technology, Tianjin University, 30072, Tianjin, China In Acknowledgement, the previous supporting project number was RSP-2023/357. Correct acknowledgement is: The authors extend their appreciation to researchers supporting project number RSP2024R357, King Saud University, Riyadh, Saudi Arabia, for funding this research. Link to the corrected article 10.2298/JSC230307050E

Correction: Isatin-based benzyloxybenzene derivatives as monoamine oxidase inhibitors with neuroprotective effect targeting neurodegenerative disease treatment

Corrigendum for “A Novel Kinase Subverts Aluminium Resistance by Boosting Ornithine Decarboxylase‐dependent Putrescine Biosynthesis”

Correction: Eid et al. Interference with TGFβ1-Mediated Inflammation and Fibrosis Underlies Reno-Protective Effects of the CB1 Receptor Neutral Antagonists AM6545 and AM4113 in a Rat Model of Metabolic Syndrome. Molecules 2021, 26, 866

Erratum: Favorable efficacy and reduced acute neurotoxicity by antisense oligonucleotides with 2',4' -BNA/LNA with 9-(aminoethoxy)phenoxazine

Erratum: Correction of author’s affiliation and acknowledgement in the article: Computer-aided approach for the identification of lead molecules as the inhibitors of cholinesterase’s and monoamine oxidases: Novel target for the treatment of Alzheimer disease

Correction: Synthesis, docking and biological evaluation of purine-5-N-isosteres as anti-inflammatory agents

Correction: Viveros-Paredes et al. Neuroprotective Effects of β-Caryophyllene against Dopaminergic Neuron Injury in a Murine Model of Parkinson's Disease Induced by MPTP. Pharmaceuticals 2017, 10, 60

Corrigendum: the Neuroprotective Effects of Fisetin, a Natural Flavonoid in Neurodegenerative Diseases: Focus on the Role of Oxidative Stress.

Correction: Dominguez-Meijide et al. Pharmacological Modulators of Tau Aggregation and Spreading. Brain Sci. 2020, 10, 858

Correction: A high-throughput effector screen identifies a novel small molecule scaffold for inhibition of ten-eleven translocation dioxygenase 2

Correction: Application of Carbon-Based Nanomaterials in Alzheimer's Disease.

Corrigendum to “Macrophage membrane-coated nanocarriers Co-Modified by RVG29 and TPP improve brain neuronal mitochondria-targeting and therapeutic efficacy in Alzheimer's disease mice” [Bioactive materials 6 (2021) 529–542]

Correction: Tiwari et al. Neuroprotective Effect of α-Mangostin in Ameliorating Propionic Acid-Induced Experimental Model of Autism in Wistar Rats. Brain Sci. 2021, 11, 288

Correction: Reyes Romero et al. Computer- and NMR-Aided Design of Small-Molecule Inhibitors of the Hub1 Protein. Molecules 2022, 27, 8282

Erratum: Author correction to '3- O-Acetyl-11-keto- β-boswellic acid ameliorated aberrant metabolic landscape and inhibited autophagy in glioblastoma' [Acta Pharm Sin B 10 (2020) 301-312]

Synthesis, in Silico and Pharmacological Evaluation of New Thiazolidine-4-Carboxylic Acid Derivatives Against Ethanol-Induced Neurodegeneration and Memory Impairment

Correction: Synthesis and Biological Evaluation of Hybrids from Farnesylthiosalicylic Acid and Hydroxylcinnamic Acid with Dual Inhibitory Activities of Ras-related Signaling and Phosphorylated NF-κB

Correction: Investigation of plasma metabolomics and neurotransmitter dysfunction in the process of Alzheimer’s disease rat induced by amyloid beta 25-35

Correction: Metal-free Oxidative Synthesis of Benzimidazole Compounds by Dehydrogenative Coupling of Diamines and Alcohols

Correction: Synthesis and anticancer evaluation of [ d -Ala]-nocardiotide A

Corrigendum to “3-(1H-benzo[d]imidazol-6-yl)-5-(4-fluorophenyl)-1, 2, 4-Oxadiazole (DDO7232), a Novel Potent Nrf2/ARE Inducer, Ameliorates DSS-Induced Murine Colitis and Protects NCM460 Cells Against Oxidative Stress Via ERK1/2 Phosphorylation”